i2a

Now the future !

i2a: diagnosis company specialized in microbiology.
Since its foundation in 1988, i2a has developped a
great know-how in bacteriology, we manufacture
and market instruments, software and reagents.

A considerable success in a very competing world,
i2a equipes about 70% of the french hospital labs
and is also positioned on the private market.

Leader in term of readers of susceptibility tests in
solid medium, with the automat SirScan2000, i2a is
the first company in the world which conceives a fully
automated system for the disc diffusion : SirScan2000 Automatic.

page 1/2